SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-009353
Filing Date
2022-01-31
Accepted
2022-01-31 10:55:26
Documents
1
Period of Report
2022-01-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2135723-2_form3.html 3  
1 OWNERSHIP DOCUMENT tm2135723-2_form3.xml 3 4341
  Complete submission text file 0001104659-22-009353.txt   6419
Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Reporting) CIK: 0001687509 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39244 | Film No.: 22571865

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Issuer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 155 EAST 44TH ST., SUITE 1630 NEW YORK NY 10017
Business Address
Rosen David Efraim (Reporting) CIK: 0001898677 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39244 | Film No.: 22571864